CNBI — China BCT Pharmacy Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual income statement for China BCT Pharmacy, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2008 March 31st	2009 March 31st	2010 December 31st	2011 December 31st	2012 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	0	0	201	257	242
Cost of Revenue
Gross Profit	—	—	48.8	61.8	48.7
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Total Operating Expenses	0.016	0.016	165	215	212
Operating Profit	-0.016	-0.016	35.4	42.2	29.4
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-0.016	-0.016	34.8	42.2	28.5
Provision for Income Taxes
Net Income After Taxes	-0.016	-0.016	25.7	31.2	21.1
Net Income Before Extraordinary Items
Net Income	-0.016	-0.016	25.7	31.2	21.1
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	-0.016	-0.016	25.7	27.3	16
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.006	-0.003	0.665	0.715	0.419
Dividends per Share